PTJ
NITE

Paul Tudor Jones’s Nightstar Therapeutics plc American Depositary Shares NITE Stock Holding History

Paul Tudor Jones’s Portfolio NITE Stock Details NITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-22,400
Closed -$430K – 1387
2017
Q3 		$430K Buy
+22,400
New +$484K 0.01% 698

Other funds holding NITE

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
TCP
Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $763M AUM 108.51% 1-Year Est. Return
CIP
Chartwell Investment Partners Berywn, Pennsylvania $2.91B AUM 40.48% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Paul Tudor Jones's NITE Position: Q4 2017 in Review

Paul Tudor Jones sold out of Nightstar Therapeutics plc American Depositary Shares (NITE) in Q4 2017, closing a stake of 22,400 shares — an estimated $430K sold.

Paul Tudor Jones first reported a position in NITE in Q3 2017 and held it in 1 quarter. The position peaked at $430K in Q3 2017. 16 funds tracked by Wall St. Rank hold NITE as of Q4 2017.

  • Paul Tudor Jones reported no remaining Nightstar Therapeutics plc American Depositary Shares position as of Q4 2017 after selling out during the quarter.
  • Paul Tudor Jones sold 22,400 Nightstar Therapeutics plc American Depositary Shares shares in Q4 2017, an estimated $430K.
  • Paul Tudor Jones first reported a position in Nightstar Therapeutics plc American Depositary Shares in Q3 2017 and held it in 1 quarter.
  • Paul Tudor Jones's Nightstar Therapeutics plc American Depositary Shares position peaked at $430K in Q3 2017.
  • 16 funds tracked by Wall St. Rank held Nightstar Therapeutics plc American Depositary Shares as of Q4 2017.

Based on Tudor Investment Corp's 13F filing for Q4 2017, filed 14 Feb 2018.